Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ:MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company’s Board of Directors (the “Board”). Mr. Durbin has more than 25 years of executive leadership, finance and clinical development experience, including the execution of over $5 billion in financings and merger transactions. In addition, the Company announced that David Hochman and Darren Sherman, independent members of the Board, have stepped down from the Board due to time requirements of their roles as Chief Executive Officer and President & COO, respectively, at Orchestra BioMed Holdings, Inc. (Nasdaq:OBIO). Their resignations are effective September 6, 2023.
Related news for (MOTS)
- Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
- 24/7 Market News Snapshot 21 Feb 2024
- Motus GI Bouncing off Its 52-Week Low
- Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract